Bollard Group LLC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 23 filers reported holding SOLENO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$93
-5.1%
2,2880.0%0.00%0.0%
Q1 2024$98
+6.5%
2,2880.0%0.00%0.0%
Q4 2023$92
+35.3%
2,2880.0%0.00%0.0%
Q3 2023$68
+580.0%
2,2880.0%0.00%
Q2 2023$10
+100.0%
2,2880.0%0.00%
Q1 2023$50.0%2,2880.0%0.00%
Q4 2022$52,2880.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 7,316,851$298,527,52127.58%
Carlyle Group Inc. 4,071,562$166,364,02315.80%
Nantahala Capital Management 3,082,107$125,749,9667.40%
Ally Bridge Group (NY) LLC 286,162$11,675,4106.96%
COMMODORE CAPITAL LP 1,425,000$58,140,0003.97%
Ghost Tree Capital, LLC 300,000$12,240,0003.83%
Vestal Point Capital, LP 1,200,000$48,960,0003.65%
Altium Capital Management LP 212,909$8,686,6873.54%
Ikarian Capital, LLC 445,451$18,174,4013.17%
Perceptive Advisors 3,204,976$130,763,0213.15%
View complete list of SOLENO THERAPEUTICS INC shareholders